·Confidence 90%
Celularity Faces Nasdaq Non-Compliance Due to 10-Q Delays
Key takeaways
- Celularity has received a non-compliance notice from Nasdaq for failing to file its 10-Q reports on time, raising concerns about its regulatory standing.
Analysis
Celularity has received a non-compliance notice from Nasdaq for failing to file its 10-Q reports on time, raising concerns about its regulatory standing.
0 likes · 0 dislikes